| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/28/2011 | WO2011048350A1 Treatment using reprogrammed mature adult cells |
| 04/28/2011 | WO2011047837A2 Melt-granulated cinacalcet |
| 04/28/2011 | WO2011047515A1 Indenoisoquinolinone derivatives, manufacturing method and medical use thereof. |
| 04/28/2011 | WO2011015953A3 Greater utility with thyroid hormone |
| 04/28/2011 | WO2011009531A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 04/28/2011 | WO2011009529A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
| 04/28/2011 | US20110098260 Steroid Compounds and Formulations |
| 04/28/2011 | US20110098259 Pregnane steroids and their use in the treatment of cns disorders |
| 04/28/2011 | US20110098220 Methods and kits for preventing hypoglycemia |
| 04/28/2011 | US20110097405 Estradiol-containing drug delivery system |
| 04/28/2011 | US20110097378 Decellularized liver for repair of tissue and treatment of organ deficiency |
| 04/28/2011 | US20110097344 Compositions, Methods for Treatment, and Diagnoses of Autoimmunity-Related Disorders and Methods for Making Such Compositions |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |
| 04/28/2011 | CA2785684A1 Melt-granulated cinacalcet |
| 04/28/2011 | CA2781522A1 Treatment using reprogrammed mature adult cells |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314609A1 Metastin derivative and use thereof |
| 04/27/2011 | EP2314301A2 Sensitization of chemotherapeutic agent-resistant neoplastic cells with various viruses |
| 04/27/2011 | EP2314286A1 Melt granulated cinacalcet |
| 04/27/2011 | EP1670444B1 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases |
| 04/27/2011 | EP1317470B1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate tumor therapy |
| 04/27/2011 | CN1639317B Probiotic lactobacillus salivarius strains |
| 04/27/2011 | CN1620302B Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12 |
| 04/27/2011 | CN102028751A Chinese medicinal composition serving as phytoestrogen and application thereof |
| 04/27/2011 | CN102028729A Method for simultaneously extracting caulis trachelospermi total lignan and total flavone |
| 04/27/2011 | CN101711756B Application of 3-phenyl-3-(4-nitryl phenylamino)-1-(4-chlorphenyl)-1-acetone as non-steroidal androgen receptor regulating agent |
| 04/27/2011 | CN101418001B Dipeptidase-IV inhibitor sulfonyl urea derivates |
| 04/27/2011 | CN101417988B Biguanide piperazines dipeptidyl peptidase IV inhibitor |
| 04/27/2011 | CN101292958B Method of preparing ultra-fine danazol powder |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2423628C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | US20110092572 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 04/21/2011 | US20110092517 Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases |
| 04/21/2011 | US20110092501 Novel inhibitors |
| 04/21/2011 | US20110092492 Imidazo compounds |
| 04/21/2011 | US20110092468 Pharmaceutical Calcimimetics |
| 04/21/2011 | US20110092448 Peptide Conjugate for Oral Delivery of Hydrophilic Peptide Analgesics |
| 04/21/2011 | US20110091539 Micronized Tanaproget and Compositions Containing Same |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091435 Phytoestrogenic formulations for alleviation or prevention of hair loss |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/20/2011 | EP2311960A2 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311847A1 Composition containing stable vitamin B6 derivative |
| 04/20/2011 | EP2311805A1 New polymorphic form of bazedoxifene acetate |
| 04/20/2011 | EP2311465A1 Remedies for diseases to be applied to eye |
| 04/20/2011 | EP2310394A1 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists |
| 04/20/2011 | EP2310037A2 Conglutin-gamma as medicament and diet supplement |
| 04/20/2011 | EP2310028A2 Suppression of neuroendocrine diseases |
| 04/20/2011 | EP2310024A2 Estrogenic extracts for use in treating vaginal and vulvar atrophy |
| 04/20/2011 | EP2309979A1 Delivery of dry formulations of octreotide |
| 04/20/2011 | EP1292592B1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 04/20/2011 | CN102026974A Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 04/20/2011 | CN102020645A Pyrazolopyrimidinone derivatives and pharmaceutical salts, preparation method and application thereof |
| 04/20/2011 | CN102020638A 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102020563A Novel curcumin analogues and uses thereof |
| 04/20/2011 | CN102018928A Method for preparing traditional Chinese medicine for treating hypothyroidism |
| 04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 04/20/2011 | CN102018688A PTP1B inhibitor and synthesis and application thereof in preparation of medicine used for treating type II diabetes |
| 04/20/2011 | CN102018672A Freeze-dried liposome composition of water-soluble medicament and preparation method thereof |
| 04/20/2011 | CN102018657A Solid dispersoid containing progestational hormone, preparation method thereof and composite comprising same |
| 04/20/2011 | CN101574409B Method of using bitter cold traditional Chinese medicine to construct animal modes with continuous low level of serum melatonin |
| 04/20/2011 | CN101313902B Traditional Chinese medicine active monomer component with liver protection function and uses thereof |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928078 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/19/2011 | US7928063 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 04/19/2011 | CA2458452C Gnrh agonist combination drugs |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/14/2011 | WO2011044307A1 Phenyloxadiazole derivatives as pgds inhibitors |
| 04/14/2011 | WO2011042477A1 Substituted pyrroles and imidazoles as estrogen receptor ligands |
| 04/14/2011 | WO2011042475A1 Substituted pyrazoles as estrogen receptor ligands |
| 04/14/2011 | US20110086097 Manufacture process for the preparation of an iron containing phosphate adsorbent |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | CA2776242A1 Phenyloxadiazole derivatives as pgds inhibitors |
| 04/13/2011 | EP2309261A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
| 04/13/2011 | EP2308880A1 Tetracyclic compound |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2307439A1 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 04/13/2011 | EP2307342A1 Diglycidic ether derivative therapeutics and methods for their use |
| 04/13/2011 | EP2307040A1 Method and means for treating viral disease, in particular hiv/aids |
| 04/13/2011 | EP2307026A1 The use of androgens for vascular regeneration and endothelial repair |
| 04/13/2011 | CN102015684A Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 04/13/2011 | CN102015638A Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient |
| 04/13/2011 | CN102015026A Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/13/2011 | CN102008474A Application of nitidine chloride to preparation of medicament for resisting autoimmunity disease and graft versus host disease |
| 04/13/2011 | CN102008468A Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases |
| 04/13/2011 | CN102008457A Metoprolol tartrate matrix sustained-release tablet |